Shukui Qin Selected Research

Shukui Qin Research Topics

Disease

76	Hepatocellular Carcinoma (Hepatoma) 06/2024 - 01/2009
54	Neoplasms (Cancer) 04/2024 - 05/2009
23	Hypertension (High Blood Pressure) 02/2024 - 04/2012
20	Disease Progression 11/2023 - 07/2011
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 05/2009
17	Stomach Neoplasms (Stomach Cancer) 11/2023 - 12/2011
15	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 06/2015
10	Adenocarcinoma 02/2024 - 12/2011
10	Neoplasm Metastasis (Metastasis) 10/2023 - 07/2014
8	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 09/2012
8	Exanthema (Rash) 01/2019 - 07/2010
7	Liver Neoplasms (Liver Cancer) 12/2023 - 02/2002
7	Carcinoma (Carcinomatosis) 01/2023 - 01/2012
7	Diarrhea 02/2022 - 04/2012
6	Hand-Foot Syndrome 01/2023 - 11/2013
6	Neutropenia 11/2022 - 07/2010
6	Proteinuria 02/2022 - 01/2015
5	Fatigue 01/2021 - 01/2009
4	Hepatic Encephalopathy 02/2024 - 11/2020
4	Thrombocytopenia (Thrombopenia) 03/2020 - 11/2013
3	Multiple Organ Failure (MODS) 02/2024 - 01/2022
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2023 - 12/2021
3	Infections 02/2023 - 01/2016
3	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 01/2014
3	Hepatitis B 12/2021 - 11/2013
3	Fibrosis (Cirrhosis) 12/2021 - 02/2015
3	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2017
3	Lung Neoplasms (Lung Cancer) 06/2018 - 08/2012
2	Sepsis (Septicemia) 02/2024 - 11/2022
2	Varicose Veins (Varicose Vein) 02/2024 - 01/2022
2	Tumor Lysis Syndrome 02/2024 - 01/2022
2	Chemical and Drug Induced Liver Injury 02/2024 - 01/2022
2	Hepatitis 02/2023 - 01/2019
2	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 11/2020
2	Stomatitis 01/2023 - 11/2022
2	Pneumonia (Pneumonitis) 12/2022 - 11/2022
2	Microsatellite Instability 12/2022 - 01/2021
2	Hepatitis C 12/2021 - 11/2013
2	Starvation 12/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

37	Sorafenib (BAY 43-9006)FDA Link 06/2024 - 01/2009
17	apatinibIBA 01/2024 - 09/2013
17	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2023 - 10/2013
13	Tyrosine Kinase InhibitorsIBA 01/2023 - 07/2011
12	Fluorouracil (Carac)FDA LinkGeneric 05/2023 - 10/2013
10	atezolizumabIBA 02/2024 - 01/2020
10	Bevacizumab (Avastin)FDA Link 11/2023 - 01/2015
9	camrelizumabIBA 01/2024 - 01/2020
9	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2019
9	Leucovorin (Folinic Acid)FDA Link 05/2023 - 10/2013
8	HMPL-013IBA 04/2024 - 01/2018
8	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2024 - 07/2012
8	Gemcitabine FDA Link 11/2023 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2017
7	Alanine Transaminase (SGPT)IBA 02/2024 - 07/2012
7	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 09/2014
7	PlatinumIBA 12/2021 - 05/2009
6	Monoclonal AntibodiesIBA 02/2024 - 01/2017
6	lenvatinibIBA 12/2023 - 01/2018
6	Proteins (Proteins, Gene)FDA Link 03/2019 - 01/2014
5	pembrolizumabIBA 12/2023 - 01/2021
5	durvalumabIBA 12/2023 - 01/2021
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 03/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2013
5	Trastuzumab (Herceptin)FDA Link 01/2021 - 02/2016
4	human ERBB2 proteinIBA 01/2023 - 02/2016
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2022 - 07/2012
4	Phosphotransferases (Kinase)IBA 01/2022 - 01/2012
4	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2015
4	Sunitinib (Sutent)FDA Link 03/2020 - 12/2011
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 02/2015
4	EndostatinsIBA 06/2018 - 08/2012
4	Axitinib (AG 013736)IBA 05/2018 - 01/2014
4	endostar proteinIBA 06/2015 - 08/2012
3	tislelizumabIBA 03/2024 - 06/2019
3	tepotinibIBA 02/2024 - 01/2018
3	tremelimumabIBA 12/2023 - 01/2021
3	surufatinibIBA 10/2023 - 11/2020
3	LigandsIBA 01/2023 - 01/2020
3	Angiogenesis InhibitorsIBA 01/2021 - 08/2012
3	regorafenibIBA 08/2020 - 06/2015
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 04/2012
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019 - 05/2016
2	cabozantinibIBA 02/2024 - 01/2022
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 02/2024 - 11/2022
2	bemarituzumabIBA 02/2024 - 11/2022
2	ProdrugsIBA 06/2023 - 01/2022
2	Cetuximab (Erbitux)FDA Link 05/2023 - 10/2018
2	Everolimus FDA Link 01/2023 - 03/2013
2	IodineIBA 01/2023 - 02/2022
2	NivolumabIBA 01/2023 - 04/2020
2	donafenibIBA 01/2023 - 01/2021
2	RamucirumabIBA 12/2022 - 12/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2018
2	ginsenoside Rg3IBA 12/2021 - 06/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 12/2017
2	Long Noncoding RNAIBA 12/2021 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 12/2021 - 02/2010

Therapy/Procedure

50	Therapeutics 01/2024 - 01/2009
45	Drug Therapy (Chemotherapy) 04/2024 - 05/2009
7	Immunotherapy 12/2023 - 12/2011